A 3D View of Genomics, Targeted Therapeutic Options, and Treatment Sequencing for the Management of Hematologic Malignancies
This activity will cover the treatment and management of patients with AML and CLL.
This activity will cover the treatment and management of patients with AML and CLL.
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This case-based live activity will cover the treatment and management of patients with hemophilia A
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This activity is intended educate PCPs, NPs, and PAs about diagnosing, treating, and managing atopic dermatitis in pediatric patients.
This case-based live activity will cover the treatment and management of patients with hemophilia A